12362882 · Active · incorporated 6 years, 8 months ago · Cambridge
Biotech B2B Deep Tech Drug Discovery Healthcare Series B+
Avatrial is a biotechnology company focused on developing personalized cancer treatments using patient-derived organoids.
Avatrial is a private limited company registered at Companies House under number 12362882, incorporated on 13 December 2019, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business covers research and experimental development on biotechnology (SIC 72110) and other professional, scientific and technical activities n.e.c. (SIC 74909). Sonde has indexed 28 filings for this company, including 3 funding rounds. Its most recent round closed in July 2026, raising £539k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Jul 2026 | £539k | £25.13 |
| Round 2 | Aug 2025 | £706k | £4.74 |
| Round 1 | Nov 2020 | £9.8m | £99.00 |
Showing the 10 most recent of 28 filings.
See the complete cap table with every shareholder, founder tags, dilution across 6 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.